Effects of flunixin meglumine on endotoxin-induced prostaglandin F2 alpha secretion during early pregnancy in mares.
The role of prostaglandin F2 alpha (PGF2 alpha) in embryonic loss following induced endotoxemia was studied in mares that were 21 to 44 days pregnant. Thirteen pregnant mares were treated with a nonsteroidal anti-inflammatory drug, flunixin meglumine, to inhibit the synthesis of PGF2 alpha caused by Salmonella typhimurium endotoxin given IV. Flunixin meglumine was administered either before injection of the endotoxin (group 1, -10 min; n = 7), or after endotoxin injection into the mares (group 2, 1 hour, n = 3; group 3, 2 hours, n = 3); 12 pregnant mares (group 4) were given only S typhimurium endotoxin. In group 4, the secretion of PGF2 alpha, as determined by plasma 15-keto-13,14-dihydro-PGF2 alpha concentrations, was biphasic, initially peaking at 30 minutes followed by a second, larger peak approximately 105 minutes after the endotoxin was given IV. When flunixin meglumine was administered at -10 minutes, synthesis of PGF2 alpha was inhibited for several hours, after administration of flunixin meglumine at 1 hour, the second secretory surge of PGF2 alpha was blocked, and administration of the drug at 2 hours did not substantially modify the secretion of PGF2 alpha. Plasma progesterone concentrations were unchanged after endotoxin injections were given in group 1. In group 2, progesterone values decreased less than 2 ng/ml and remained low for several days. In group 3 and group 4, progesterone concentrations decreased to values less than 0.5 ng/ml by 48 hours after endotoxin injections were given.(ABSTRACT TRUNCATED AT 250 WORDS)
Daels
P F
PF
Department of Reproduction, School of Veterinary Medicine, University of California, Davis 95616.
Stabenfeldt
G H
GH
Hughes
J P
JP
Odensvik
K
K
Kindahl
H
H
D000034:Abortion, Veterinary / Q000209:etiology*; D000818:Animals; D003002:Clonixin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D015237:Dinoprost / Q000096:biosynthesis*; D004731:Endotoxins / Q000633:toxicity*; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D006736:Horses; D007275:Injections, Intravenous / Q000662:veterinary; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D012486:Salmonella typhimurium; D012772:Shock, Septic / Q000139:chemically induced / Q000662:veterinary; D013997:Time Factors
D004731:Endotoxins; D011374:Progesterone; C014558:flunixin meglumine; D015237:Dinoprost; D003002:Clonixin